Credit Suisse’s Virtus Biotech ETF BBP Stock Holding History

Credit Suisse’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-23,011	Closed	-$635K	–	4211
2015 Q3	$635K	Buy	23,011 +8,027	+54%	+$271K	﹤0.01%	3218
2015 Q2	$526K	Sell	14,984 -167	-1%	-$5.49K	﹤0.01%	3679
2015 Q1	$470K	Buy	+15,151	New	+$444K	﹤0.01%	3583

Other funds holding BBP

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Credit Suisse's BBP Position: Q4 2015 in Review

Credit Suisse sold out of Virtus Biotech ETF (BBP) in Q4 2015, closing a stake of 23,011 shares — an estimated $635K sold.

Credit Suisse first reported a position in BBP in Q1 2015 and held it in 3 quarters. The position peaked at $635K in Q3 2015. 15 funds tracked by Wall St. Rank hold BBP as of Q4 2015.

Credit Suisse reported no remaining Virtus Biotech ETF position as of Q4 2015 after selling out during the quarter.
Credit Suisse sold 23,011 Virtus Biotech ETF shares in Q4 2015, an estimated $635K.
Credit Suisse first reported a position in Virtus Biotech ETF in Q1 2015 and held it in 3 quarters.
Credit Suisse's Virtus Biotech ETF position peaked at $635K in Q3 2015.
15 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2015.

Based on Credit Suisse's 13F filing for Q4 2015, filed 16 Feb 2016.